share_log

Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $121

Benzinga ·  Dec 13, 2023 10:13

Wells Fargo analyst Lawrence Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $116 to $121.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment